Clinical trial
The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy
NCT06318507
Study timeline
Study start (actual)2024-03-11Date precision: day
Registry last updated2025-02-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Neoplasmsunresolved
Interventions
Fecal microbial diversityCOMBINATION_PRODUCT
Sponsors & collaborators
Pennington Biomedical Research Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06318507 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.